NCT06783686View on ClinicalTrials.gov

Evaluation of NV701 (Pilocarpine 1.25%) Compared With Vuity (Pilocarpine 1.25%) on Pupil Size in Subjects With Presbyopia

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 30, 2025

Primary Completion Date

April 4, 2025

Study Completion Date

May 7, 2025

Conditions

Pupil Constriction

Interventions

DRUG

NV701

eye drop

DRUG

Pilocarpine 1.25% Eye drop

eye drop

Trial Locations (2)

85224

Arizona Eye Center, Chandler

91204

Global Research Management, Inc, Glendale

All Listed Sponsors

lead

Novus Vision LLC

INDUSTRY

NCT06783686 - Evaluation of NV701 (Pilocarpine 1.25%) Compared With Vuity (Pilocarpine 1.25%) on Pupil Size in Subjects With Presbyopia | Biotech Hunter | Biotech Hunter